Biodesix Total Liab from 2010 to 2024

BDSX Stock  USD 1.36  0.02  1.49%   
Biodesix Total Liabilities yearly trend continues to be fairly stable with very little volatility. Total Liabilities is likely to outpace its year average in 2024. Total Liabilities is the total amount of all liabilities that Biodesix has, including both short-term and long-term liabilities. View All Fundamentals
 
Total Liabilities  
First Reported
2010-12-31
Previous Quarter
94.5 M
Current Value
108 M
Quarterly Volatility
78.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Biodesix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biodesix's main balance sheet or income statement drivers, such as Interest Income of 25.9 K, Depreciation And Amortization of 3.2 M or Interest Expense of 6.5 M, as well as many indicators such as Price To Sales Ratio of 2.92, Dividend Yield of 0.0 or PTB Ratio of 34.64. Biodesix financial statements analysis is a perfect complement when working with Biodesix Valuation or Volatility modules.
  
Check out the analysis of Biodesix Correlation against competitors.
For more information on how to buy Biodesix Stock please use our How to Invest in Biodesix guide.

Latest Biodesix's Total Liab Growth Pattern

Below is the plot of the Total Liab of Biodesix over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. Biodesix's Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biodesix's overall financial position and show how it may be relating to other accounts over time.
Total Liab10 Years Trend
Slightly volatile
   Total Liab   
       Timeline  

Biodesix Total Liab Regression Statistics

Arithmetic Mean187,672,769
Geometric Mean166,665,382
Coefficient Of Variation41.75
Mean Deviation70,296,975
Median237,087,000
Standard Deviation78,360,860
Sample Variance6140.4T
Range213.8M
R-Value(0.76)
Mean Square Error2829.6T
R-Squared0.57
Significance0
Slope(13,253,183)
Total Sum of Squares85965.9T

Biodesix Total Liab History

2024108 M
202394.5 M
202272.3 M
202156.4 M
202079.9 M
2019270.2 M

About Biodesix Financial Statements

Biodesix investors use historical fundamental indicators, such as Biodesix's Total Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biodesix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Liabilities94.5 M108 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Biodesix Stock Analysis

When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.